Cargando…
Immune Modulation to Improve Survival of Viral Pneumonia in Mice
Viral pneumonias remain global health threats, as exemplified in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, requiring novel treatment strategies both early and late in the disease process. We have reported that mice treated before or soon after infection with a combin...
Autores principales: | Wali, Shradha, Flores, Jose R., Jaramillo, Ana M., Goldblatt, David L., Pantaleón García, Jezreel, Tuvim, Michael J., Dickey, Burton F., Evans, Scott E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Thoracic Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7790135/ https://www.ncbi.nlm.nih.gov/pubmed/32853024 http://dx.doi.org/10.1165/rcmb.2020-0241OC |
Ejemplares similares
-
Airway Epithelial Innate Immunity
por: Johnston, Sebastian L., et al.
Publicado: (2021) -
Epithelial immunomodulation by aerosolized Toll-like receptor agonists prevents allergic inflammation in airway mucosa in mice
por: Goldblatt, David L., et al.
Publicado: (2022) -
Synergistic TLR2/6 and TLR9 Activation Protects Mice against Lethal Influenza Pneumonia
por: Tuvim, Michael J., et al.
Publicado: (2012) -
Inducible Lung Epithelial Resistance Requires Multisource Reactive Oxygen Species Generation To Protect against Viral Infections
por: Kirkpatrick, Carson T., et al.
Publicado: (2018) -
Allergic lung inflammation alters neither susceptibility to Streptococcus pneumoniae infection nor inducibility of innate resistance in mice
por: Clement, Cecilia G, et al.
Publicado: (2009)